Blueprint Medicines Corp Price Chart
Blueprint Medicines Corp 2L9.BE Financial and Trading Overview
| Blueprint Medicines Corp stock price | 93.68 EUR |
| Previous Close | 53.5 EUR |
| Open | 55 EUR |
| Bid | 55 EUR x 0 |
| Ask | 56.5 EUR x 0 |
| Day's Range | 55 - 55 EUR |
| 52 Week Range | 35.53 - 75.9 EUR |
| Volume | 50 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
2L9.BE Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Blueprint Medicines Corp Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 75.9 EUR |
| 52 Week Low | 35.53 EUR |
| 50-Day Moving Average | 46.9 EUR |
| 200-Day Moving Average | 48.31 EUR |
2L9.BE Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For Blueprint Medicines Corp Stock
What is a current 2L9.BE stock price?
Blueprint Medicines Corp 2L9.BE stock price today per share is 93.68 EUR.
How to purchase Blueprint Medicines Corp stock?
You can buy 2L9.BE shares on the Berlin exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Blueprint Medicines Corp?
The stock symbol or ticker of Blueprint Medicines Corp is 2L9.BE.
How many shares does Blueprint Medicines Corp have in circulation?
The max supply of Blueprint Medicines Corp shares is 0.
What is Blueprint Medicines Corp Price to Earnings Ratio (PE Ratio)?
Blueprint Medicines Corp PE Ratio is now.
What was Blueprint Medicines Corp earnings per share over the trailing 12 months (TTM)?
Blueprint Medicines Corp EPS is 0 EUR over the trailing 12 months.